Focus Stocks
NIKE Is Approaching its 200 Day Moving Average
Published on Sunday, 24 June 2012 00:36 Written by TradersHuddle Wire
New York, June 24th (TradersHuddle.com) - NIKE, Inc. (NYSE:NKE) closed the trading session at $99.40, near its 200 day moving average set at $100.77. NIKE's stock action is below this level, which makes the stock difficult to be bought, as it will face resistance as it approaches its 200 day moving average.
NIKE, Inc. (NYSE:NKE) designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children worldwide. The Company sell its products to retail stores, through its own stores, and through a mix of independent distributors and licensees.
Latest price action range, defined by a peaks and troughs algorithm, placed calculated support at $99.36 and resistance at $109.91. Traders should closely monitor these levels, as they provide great reference points for the latest price action in NIKE.
If traders want to establish a position on NIKE, given that resistance could materialize as the stock approaches its 200 day moving average, a trade might materialize as the stock manages to break this important level. After the breakout, the 200 day moving average could be used as support going forward. However, until the break materializes, traders need to exercise patience.
Related Articles
- NIKE Is Near a Key Resistance Area
- Trading Idea: Is NIKE Breaking Out?
- NIKE Is Close to Resistance
- Is NIKE Closing in to Resistance?
- NIKE Broke Resistance
- NIKE Is Near Resistance
- Trading Idea: Is NIKE Breaking Out?
- NIKE Broke Resistance
- Critical Alerts For Halliburton, Nike, 3D Systems, TakeTwo Interactive, and Robert Half International Released By InvestorsObserver
- NIKE Is Close to Resistance
Related Partner Headlines
- Nike Inc. (NKE): Today's Featured Consumer Goods Winner - TheStreet.com
- NIKE Announces 17% Increase in Quarterly Dividend and Two-for-One Stock Split - Benzinga
- Nike Inc. (NKE): Today's Featured Consumer Goods Laggard - TheStreet.com
- Nike Inc. Stock Buy Recommendation Reiterated (NKE) - TheStreet.com
- Nike Inc. (NKE): Today's Featured Consumer Goods Winner - TheStreet.com
- Nike Inc. Stock Buy Recommendation Reiterated (NKE) - TheStreet.com
- Nike Boots Umbro (NKE, ICON, UA) - Investopedia
- Nike Inc. (NKE): Today's Featured Consumer Non-Durables Laggard - TheStreet.com
- Everything Lance Armstrong Has Done Means Nothing Now - TheStreet.com
- Lance Armstrong Suffers Flat Tire: Nike Cancels Contract - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,354.40 Trade time:4:40PM EDT Value change:▲121.18 (0.80%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,667.47 Trade time:4:39PM EDT Value change:▲17.00 (1.03%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,498.97 Trade time:5:15PM EDT Value change:0.00 (0.00%)In The Wires
-
Perfect World Unveils New 3D Fantasy MMORPG "Holy King" in its Pipeline -
Boeing Showcases BBJ 3 for the First Time at EBACE 2013 -
AUO Publishes 65-inch Full HD OLED Panel Technology Paper at SID Display Week -
Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to Improve Tacrolimus-Induced Tremors -
EBACE 2013: Honeywell Aerospace Highlights Momentum In Europe, Middle East For Aircraft Upgrades -
ASE Assembly & Test (Shanghai) Limited to Acquire Shares of Wuxi Tongzhi Microelectronics Co., Ltd. from Toshiba Semiconductor (Wuxi) Co., Ltd. -
Tetragon Financial Group Limited (TFG) Monthly Update For April 2013 -
German Federal Joint Committee (G-BA) Issues Final Assessment Report for PIXUVRI® (pixantrone)








